Metrion Biosciences announced the appointment of Dr Andrew Southan as chief executive officer effective immediately. Dr Southan was previously the Company’s chief operating officer.   Dr Southan joined Metrion as head of Commercial Operations in October 2016, was promoted to chief operating officer in April 2017, and joined the board as a director in March 2018. During this period the Company has made significant progress, developing innovative, high-quality assays for its clients and expandin...